Identification of such interactions between KRAS and TAMs provides a better understanding of the mechanisms by which KRAS affects CRC pathogenesis, and might provide novel insights on potential therapeutic strategies for treating KRAS mutant tumors. Here, KRAS is linked to colorectal carcinoma.